Status:
COMPLETED
Study of a Pandemic Influenza Vaccine in Children
Lead Sponsor:
Seqirus
Conditions:
Influenza
Eligibility:
All Genders
6-8 years
Phase:
PHASE2
Brief Summary
The World Health Organisation has warned that an influenza pandemic is inevitable. The avian influenza strain H5N1 is one of the leading candidates to cause the next influenza pandemic. Children are l...
Eligibility Criteria
Inclusion
- Healthy children aged greater or equal to 6 months to less than 9 years
- Normal gestation period
Exclusion
- History of clinically significant medical conditions
- History of Guillain Barre syndrome or active neurological disease
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2007
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT00370864
Start Date
September 1 2006
End Date
July 1 2007
Last Update
July 19 2016
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Murdoch Childrens Research Institute
Melbourne, Victoria, Australia, 3052
2
Princess Margaret Hospital for Children
Perth, Western Australia, Australia